Colon cancer is one of the most common type of reported cancer in the world. The prevalence of colon cancer is growing with each year and clinical adjustments are in line for detecting the cause before late stage development. Colon cancer if detected at an early stage can be treated by removing the premalignant polyps. Non-invasive colon cancer screening is one of the medium to detect cancer cells presence. Scientists are developing better ways to detect colon cancer which can be inexpensive and safe at the same time. There are more number of invasive procedures present to detect cancer, gold standard of colorectal cancer screening still is colonoscopy.
Non-invasive Colon Cancer Screening Market: Drivers and Restraints
The market for non-invasive colon cancer screening is growing in terms of adoption, the present use of non-invasive colon cancer screening is visible in healthcare settings like hospitals. At present there are only very few companies operating in this market, primarily only one FDA approved product is there in the market. The main attractive segment for non-invasive colon cancer screening is the home settings where most of the screening test can be performed. The scenario for non-invasive colon cancer screening would change with number products in line to enter the market. The ease with non-invasive colon cancer screening makes it a fast growing technology with considerable adoption rate. There are research initiatives present for non-invasive colon cancer screening, the market structure for now only consists of one significant player. There are more than 100K new cases of colon cancer in US in 2019, the healthcare spending for cancer is huge and colorectal cancer is one of the leading type of cancer in terms of treatment spending
Non-invasive Colon Cancer Screening Market: Overview
The global market for non-invasive colon cancer screening would experience the emergence of new manufacturers and better technological advances. The current structure of the non-invasive colon cancer screening market include Cologuard test kit from Exact Sciences Corporation, as it is the only product which has received FDA approval, it is also the only type of non-invasive colon cancer screening device which detects colon cancer based on DNA stool sample. Each of the test type uses different type of technology and delivers a better test result than the other. Though the market for non-invasive colon cancer screening competes with invasive technologies like flexible sigmoidoscopy and colonoscopy. Invasive screening still provides a quick responsive result at the time, whereas non-invasive colon cancer screening laboratory work in order to find the results. The result can be false negative using a non-invasive colon cancer screening which limits the use and accuracy of the test.
Non-invasive Colon Cancer Screening Market: Regional Wise Outlook
Geographically, the non-invasive colon cancer screening market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa. The South Asia non-invasive colon cancer screening market is a lucrative market opportunity for manufacturers, with present infrastructure promoting better screening needs, such factors makes it an opportunity full market space. Europe region has a considerable share in the non-invasive colon cancer screening market. Indirect sales around emerging economies shows a more attractive growth.
There are less players involved in the market of non-invasive colon cancer screening including Exact Sciences Corporation and Laboratory Corporation of America Holdings. The present market structure of non-invasive colon cancer screening is expected to change with efforts and research present in clinical phase.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology Matrix
- Value Chain
Regional analysis of the Non-invasive Colon Cancer Screening market report includes
- North America
- Latin America
- South Asia
- East Asia
- Middle East and Africa
Non-invasive Colon Cancer Screening Market: Segmentation
Tentatively, the global non-invasive colon cancer screening market has been segmented on the basis of test type, end user and geography.
Based on test type, the global non-invasive colon cancer screening market is segmented as:
- Fecal immunochemical test
- Guaiac-based fecal occult blood test (gFOBT)
- Stool DNA test
Based on end user, the global non-invasive colon cancer screening market is segmented as:
- Ambulatory Surgical Centers
- Specialty Clinic
- Home care setting
Non-invasive Colon Cancer Screening Market Report Highlights:
- Overview of Global Healthcare Market
- Evolution of the technology
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.